3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is ever more attracting clinical scrutiny due to limited evidence suggesting unique pharmacological actions. Current studies demonstrate that https://www.pinterest.com/pin/1140888518124046392/